Medherant Limited
PrivateLast Round
Series A
Apr 3, 2023
Total Funding Raised
$6.37M
Company Overview
Medherant Limited operates in Healthcare & Life Sciences and is based in Coventry. Its latest recorded funding round was a Series A round in April 2023.
Medherant Limited is a pharmaceutical company that develops innovative transdermal drug delivery therapies using its proprietary TEPI Patch® technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medherant Limited Comparables
Compare Medherant Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mission Pharmacal Company | 80% | |
| Anodyne Nanotech | 78% | |
| DifGen Pharmaceuticals | 75% |
For institutional investors. Book with your work email.
Medherant Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 3, 2023 | ||||
| VC Round | May 21, 2019 | ||||
| VC Round | Dec 11, 2017 | ||||
| Seed | Sep 27, 2016 | ||||
| Seed | May 6, 2016 | ||||
Seed | Jun 5, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Medherant Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mercia Asset Management | Seed, VC Round, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 544% MoM, reaching 1.8K.
- Apr 3, 2023
$4M round led by Mercia Asset Management.
For institutional investors. Book with your work email.
Medherant Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Medherant Limited's valuation, stock price, and market status.
Is Medherant Limited a public or private company?
Medherant Limited is a private company.
What is the current stock price of Medherant Limited?
Medherant Limited is a private company, so its shares have no public market price. Caplight tracks Medherant Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medherant Limited worth (valuation)?
Valuation information for Medherant Limited is not publicly available.
Can I buy Medherant Limited stock?
Medherant Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medherant Limited's last funding round?
Medherant Limited's most recent funding round was Series A on April 3, 2023.
Who are the main investors in Medherant Limited?
Key investors in Medherant Limited include Mercia Asset Management.
Will Medherant Limited IPO soon?
No public IPO plans have been announced for Medherant Limited.
How can I track Medherant Limited secondary market activity?
Caplight tracks bids, offers, and trades in Medherant Limited's shares on secondary markets.